Patent Assignment
Reel/Frame 057453/0815
Change of Name
Recorded: 2021-09-09
Pages: 3
Assignor
M3 BIOTECHNOLOGY, INC.
Executed: 2019-03-13
Assignee
ATHIRA PHARMA, INC.
4000 MASON RD, SUITE 300, BOX 352141, SEATTLE, WASHINGTON, 98195-2141
Covered Property
(1)
Methods of Treating Neurodegenerative Disease with Substituted N-Hexanoic-L-Tyrosine-L-Isoleucine-(6)-Aminohexanoic Amide Analogues
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.